Matinas BioPharma Holdings, Inc. (MTNB)
0.65
0.00 (0.00%)
USD |
NYAM |
Jun 24, 16:00
0.6628
+0.01
(+1.97%)
After-Hours: 04:12
Matinas BioPharma Holdings Price to Book Value : 1.378 for June 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 24, 2026 | 1.378 |
| June 23, 2026 | 1.378 |
| June 22, 2026 | 1.338 |
| June 18, 2026 | 1.280 |
| June 17, 2026 | 1.505 |
| June 16, 2026 | 1.527 |
| June 15, 2026 | 1.594 |
| June 12, 2026 | 1.654 |
| June 11, 2026 | 1.720 |
| June 10, 2026 | 1.685 |
| June 09, 2026 | 1.689 |
| June 08, 2026 | 1.738 |
| June 05, 2026 | 1.673 |
| June 04, 2026 | 1.696 |
| June 03, 2026 | 1.649 |
| June 02, 2026 | 1.624 |
| June 01, 2026 | 1.848 |
| May 29, 2026 | 1.717 |
| May 28, 2026 | 1.684 |
| May 27, 2026 | 1.549 |
| May 26, 2026 | 1.543 |
| May 22, 2026 | 1.493 |
| May 21, 2026 | 1.420 |
| May 20, 2026 | 1.352 |
| May 19, 2026 | 1.181 |
| Date | Value |
|---|---|
| May 18, 2026 | 1.145 |
| May 15, 2026 | 1.189 |
| May 14, 2026 | 1.213 |
| May 13, 2026 | 1.196 |
| May 12, 2026 | 1.251 |
| May 11, 2026 | 1.357 |
| May 08, 2026 | 1.353 |
| May 07, 2026 | 1.367 |
| May 06, 2026 | 1.442 |
| May 05, 2026 | 1.38 |
| May 04, 2026 | 1.420 |
| May 01, 2026 | 1.482 |
| April 30, 2026 | 1.379 |
| April 29, 2026 | 1.300 |
| April 28, 2026 | 1.263 |
| April 27, 2026 | 1.293 |
| April 24, 2026 | 1.293 |
| April 23, 2026 | 1.308 |
| April 22, 2026 | 1.188 |
| April 21, 2026 | 1.166 |
| April 20, 2026 | 1.164 |
| April 17, 2026 | 1.060 |
| April 16, 2026 | 1.113 |
| April 15, 2026 | 1.113 |
| April 14, 2026 | 1.121 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.202 |
| Alnylam Pharmaceuticals, Inc. | 36.49 |
| Anika Therapeutics, Inc. | 1.469 |
| Savara, Inc. | 6.787 |
| Vericel Corp. | 5.970 |
Price to Book Value Related Metrics
| Price | 0.65 |
| Earnings Yield | -311.5% |
| Market Cap | 4.164M |